These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7587028)

  • 21. Cefotaxime, desacetyl-cefotaxime, and bactericidal activity in spontaneous bacterial peritonitis.
    Dalmau D; Layrargues GP; Fenyves D; Willems B; Turgeon F; Turgeon P
    J Infect Dis; 1999 Nov; 180(5):1597-602. PubMed ID: 10515821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of replacing cefotaxime with ceftizoxime in a hospital where penicillin-resistant pneumococcal disease is prevalent.
    Haas DW; Bonczar T
    J Antimicrob Chemother; 1996 Aug; 38(2):293-9. PubMed ID: 8877545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacoeconomic aspects of antibacterial treatment with cefotaxime.
    Cooke J; Doreau C; Eandi M
    J Chemother; 1997 May; 9 Suppl 2():34-45. PubMed ID: 9248974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
    Lorenz J
    Chemotherapy; 1998 Sep; 44 Suppl 1():15-8. PubMed ID: 9797418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis.
    Rimola A; Navasa M; Arroyo V
    Diagn Microbiol Infect Dis; 1995; 22(1-2):141-5. PubMed ID: 7587029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ceftriaxone compared with cefotaxime for serious bacterial infections.
    Smith CR; Petty BG; Hendrix CW; Kernan WN; Garver PL; Fox K; Beamer A; Carbone K; Threlkeld M; Lietman PS
    J Infect Dis; 1989 Sep; 160(3):442-7. PubMed ID: 2668428
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynaecological infections.
    Newton ER; Yeomans ER; Pastorek JG; Soper DE; Hemsell DL
    J Antimicrob Chemother; 1993 Nov; 32 Suppl B():195-204. PubMed ID: 8150763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients.
    de Pauw BE; Kauw F; Muytjens H; Williams KJ; Bothof T
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():93-9. PubMed ID: 6311790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.
    Höffken G; Pasold R; Pflüger KH; Finke J; Fauser AA; Szelenyi H; Wagner J
    J Antimicrob Chemother; 1999 Sep; 44(3):367-76. PubMed ID: 10511404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of pharmacokinetics and pharmacodynamics in the design of dosage schedules for 12-h cefotaxime alone and in combination with other antibiotics.
    Nix DE; Schentag JJ
    Diagn Microbiol Infect Dis; 1995; 22(1-2):71-6. PubMed ID: 7587053
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital.
    Rawlings RD
    Diagn Microbiol Infect Dis; 1995; 22(1-2):235-7. PubMed ID: 7587046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of frequency of administration on therapeutic efficacy of cefotaxime.
    Parker RH
    Clin Ther; 1984; 6(4):488-99. PubMed ID: 6088045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cost-effectiveness analysis of ceftriaxone and cefotaxime in the treatment of community-acquired pneumonia].
    García-Contreras F; Del-Angel-García G; Ramírez Cuenca A; Malváez-Valdes M; Vega Yáñez A; Amato D
    Rev Invest Clin; 2000; 52(4):418-26. PubMed ID: 11061104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of cefotaxime in dialysis patients.
    Andrassy K
    Diagn Microbiol Infect Dis; 1995; 22(1-2):85-7. PubMed ID: 7587055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients.
    Ricart E; Soriano G; Novella MT; Ortiz J; Sàbat M; Kolle L; Sola-Vera J; Miñana J; Dedéu JM; Gómez C; Barrio JL; Guarner C
    J Hepatol; 2000 Apr; 32(4):596-602. PubMed ID: 10782908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cefotaxime in the treatment of spontaneous bacterial peritonitis.
    Xiol X; Ariza J
    Hepatology; 1996 Apr; 23(4):941-2. PubMed ID: 8666356
    [No Abstract]   [Full Text] [Related]  

  • 37. Cefotaxime in the treatment of prophylaxis of surgical infections.
    Wittmann DH; Jones RN; Malledant J; Privitera G
    J Chemother; 1997 May; 9 Suppl 2():19-33. PubMed ID: 9248973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial.
    Li JT; Lu Y; Hou J; Chen YF; Miao JZ; Jia YX; Hou J; Zhang XZ; Chen DK; Hu WZ; Li LJ; Liu DM; Wang Z; Wu J; Gu JM; Wang HL; Zhang YL; Sun L
    Clin Infect Dis; 1997 Mar; 24(3):498-505. PubMed ID: 9114206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cefotaxime and desacetylcefotaxime antimicrobial interactions. The clinical relevance of enhanced activity: a review.
    Jones RN
    Diagn Microbiol Infect Dis; 1995; 22(1-2):19-33. PubMed ID: 7587039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Update on the use of cefotaxime for pediatric meningitis in Portugal.
    Lecour H; Miranda AM; Nogueira JA; Abreu C
    Diagn Microbiol Infect Dis; 1995; 22(1-2):125-7. PubMed ID: 7587025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.